{"id":"W2587875644","doi":"10.1136/gutjnl-2016-312735","title":"Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials","year":2017,"lang":"en","type":"article","venue":"Gut","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":361,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; University of Calgary","funders":"Pfizer; GlaxoSmithKline; Amgen; American College of Gastroenterology; Eli and Edythe Broad Foundation","keywords":"Tofacitinib; Placebo; Crohn's disease; Medicine; Internal medicine; Maintenance therapy; Clinical trial; Physical therapy; Disease; Alternative medicine; Pathology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00145407,0.0001334066,0.0005141534,0.00003045583,0.0001054109,0.0000234297,0.0001532528,0.00007147526,0.000009214938],"category_scores_gemma":[0.005036457,0.0001023054,0.0002851013,0.000009518287,0.0001683975,0.000008050474,0.00003285459,0.00002984474,4.043802e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000004362789,"about_ca_system_score_gemma":0.0001105648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007448331,"about_ca_topic_score_gemma":0.000005238781,"domain_scores_codex":[0.9987843,0.0001739827,0.0005590848,0.0002427367,0.00009407846,0.000145819],"domain_scores_gemma":[0.9981005,0.00009649652,0.001023938,0.0005087779,0.000178074,0.00009217952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5970587,0.0001288194,0.0002355257,0.00004516792,0.0002201239,0.00001110183,0.00003841082,0.0000126225,0.3956953,0.000124897,0.0009670891,0.005462217],"study_design_scores_gemma":[0.832109,0.0002703802,0.02519227,0.00006204682,0.0001637438,0.000001411231,0.00003005154,0.0002148497,0.1374536,0.0005549991,0.003722754,0.0002248741],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958171,0.0003973623,0.0004660556,0.000117039,0.0001521436,0.001959034,0.0007774928,0.000004961699,0.0003088009],"genre_scores_gemma":[0.9985324,0.0002618599,0.000190429,0.00003442286,0.0002054121,0.0002343207,0.0001167332,0.00001373068,0.0004106918],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2582417,"threshold_uncertainty_score":0.6029474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03372392994722092,"score_gpt":0.3415235518266941,"score_spread":0.3077996218794732,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}